V029-9021 Screening compound: N-[1-(4-fluorophenyl)-3-phenyl-1H-pyrazol-5-yl]-2-{N-pentyl-1-[4-(trifluoromethyl)phenyl]formamido}acetamide

V029-9021 Screening compound: N-[1-(4-fluorophenyl)-3-phenyl-1H-pyrazol-5-yl]-2-{N-pentyl-1-[4-(trifluoromethyl)phenyl]formamido}acetamide
V029-9021 Screening compound: N-[1-(4-fluorophenyl)-3-phenyl-1H-pyrazol-5-yl]-2-{N-pentyl-1-[4-(trifluoromethyl)phenyl]formamido}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V029-9021
N-[1-(4-fluorophenyl)-3-phenyl-1H-pyrazol-5-yl]-2-{N-pentyl-1-[4-(trifluoromethyl)phenyl]formamido}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V029-9021

Molecular Formula

C30H28F4N4O2 (C30 H28 F4 N4 O2)

Compound Name

N-[1-(4-fluorophenyl)-3-phenyl-1H-pyrazol-5-yl]-2-{N-pentyl-1-[4-(trifluoromethyl)phenyl]formamido}acetamide

IUPAC name

N-[1-(4-fluorophenyl)-3-phenyl-1H-pyrazol-5-yl]-2-{N-pentyl-1-[4-(trifluoromethyl)phenyl]formamido}acetamide

SMILES

CCCCCN(CC(Nc1cc(-c2ccccc2)nn1-c(cc1)ccc1F)=O)C(c1ccc(C(F)(F)F)cc1)=O

InChI

InChI=1S/C30H28F4N4O2/c1-2-3-7-18-37(29(40)22-10-12-23(13-11-22)30(32,33)34)20-28(39)35-27-19-26(21-8-5-4-6-9-21)36-38(27)25-16-14-24(31)15-17-25/h4-6,8-17,19H,2-3,7,18,20H2,1H3,(H,35,39)

InChI Key

SLSOLRMGCNHBEG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19719133

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

552.57

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

7.352

Distribution Coefficient, logD

7.352

Water Solubility, LogSw

-5.70

Polar Surface Area

53.741

Acid Dissociation Constant (pKa)

13.56

Base Dissociation Constant (pKb)

-2.72

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.30

V029-9021 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

PD-1/L1 Library (498 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
  • Cancer
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Mechanism of action:
  • Epigenetic
Targets:
  • Others

References: we are preparing a list of scientific research reports with V029-9021 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V029-9021?
Check Price and Availability of V029-9021, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V029-9021 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V029-9021
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V029-9021
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V029-9021 available by request